BioSpace News Archive

Gimv, Sofinnova and Gilde Healthcare announced the sale of biopharmaceutical company Breath Therapeutics.

Evotec SE announced that the Company has been informed by Bayer about positive Phase IIa results from a study surveying the safety, efficacy and dosage of the compound BAY1817080 in refractory chronic cough.

Net sales increased 10 per cent compared to Q2 2018, corresponding to the net of acquisitions and discontinuing operations.

The project, led by researchers at the Wellcome Sanger Institute and Massachusetts General Hospital, builds on the previous six years’ study, and practically doubles the volume of novel data available on the website – making it the largest public dataset of its kind in the world.

sterna biologicals selected as one of a group of top-tier European biotech companies to present at the European Biotech Investor Day on August 1, 2019 in New York City

Eurofins Scientific, a world leader in biopharmaceutical testing acquired Alphora Research Inc. to support Eurofins’ extensive drug development platform.

MorphoSys AG will publish its first six months’ 2019 results on August 6, 2019 at 10:00pm CEST.

hematologists and multiple myeloma patients in the UK will have access to Dutch developed diagnostic test MMprofilerTM with SKY92 algorithm through the diagnostic service provided by Everything Genetic Ltd. SkylineDx, the diagnostics company that developed the test, announced its collaboration with the UK based provider of a genetic testing service.

Bioz, Inc., a Silicon Valley AI data company for life science research and recipient of the prestigious Gartner Cool Vendor award, is excited to announce the expansion of its Bioz Badges program to further increase the ROI of life science product marketing.

Eurofins Scientific, a world leader in biopharmaceutical testing acquired Amatsigroup SAS to support Eurofins’ extensive drug development platform.